SWAN Isotopen AG, Bern   Report issue

For profit Phase 2
Founded: Bern Switzerland (2007)
Status: No NME R&D (2007)

Organization Overview

First Clinical Trial
2014
NCT02078843
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now